Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amanda R Patrick

Showing results (1-10 of 53) with videos related to

Pageof 6
Sort By:
Clinical Therapeutics|July 11, 2003
Estimates of direct medical costs for microvascular and macrovascular complications resulting from type 2 diabetes mellitus in the United States in 2000Judith A O'Brien, Amanda R Patrick, Jaime Caro
Circulation. Cardiovascular Quality and Outcomes|December 25, 2009
Cost-effectiveness of genotype-guided warfarin dosing for patients with atrial fibrillationAmanda R Patrick, Jerry Avorn, Niteesh K Choudhry
Journal of General Internal Medicine|January 5, 2011
Healthy user and related biases in observational studies of preventive interventions: a primer for physiciansWilliam H Shrank, Amanda R Patrick, M Alan Brookhart
BMC Health Services Research|March 28, 2003
Cost of managing complications resulting from type 2 diabetes mellitus in CanadaJudith A O'Brien, Amanda R Patrick, J Jaime Caro
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|January 21, 2014
The potential economic benefits of improved postfracture care: a cost-effectiveness analysis of a fracture liaison service in the US health-care systemDaniel H Solomon, Amanda R Patrick, John Schousboe, et al.
Pharmacoeconomics|October 27, 2007
Strategies for the management of suspected heparin-induced thrombocytopenia: a cost-effectiveness analysisAmanda R Patrick, Wolfgang C Winkelmayer, Jerry Avorn, et al.
Journal of Clinical Psychopharmacology|November 14, 2009
Health advisories and patterns of patient monitoring among new users of antidepressant medicationsJoshua J Gagne, Amanda R Patrick, Philip S Wang, et al.
Journal of the American College of Cardiology|February 12, 2011
The cost-effectiveness of C-reactive protein testing and rosuvastatin treatment for patients with normal cholesterol levelsNiteesh K Choudhry, Amanda R Patrick, Robert J Glynn, et al.
The Journal of Clinical Endocrinology and Metabolism|July 8, 2011
The economics of improving medication adherence in osteoporosis: validation and application of a simulation modelAmanda R Patrick, John T Schousboe, Elena Losina, et al.
BMC Health Services Research|September 4, 2003
Cost of managing an episode of relapse in multiple sclerosis in the United StatesJudith A O'Brien, Alexandra J Ward, Amanda R Patrick, et al.
Pageof 6

Showing results (1-10 of 53) with videos related to

Sort By:
Pageof 6
Clinical Therapeutics|July 11, 2003
Estimates of direct medical costs for microvascular and macrovascular complications resulting from type 2 diabetes mellitus in the United States in 2000Judith A O'Brien, Amanda R Patrick, Jaime Caro
Circulation. Cardiovascular Quality and Outcomes|December 25, 2009
Cost-effectiveness of genotype-guided warfarin dosing for patients with atrial fibrillationAmanda R Patrick, Jerry Avorn, Niteesh K Choudhry
Journal of General Internal Medicine|January 5, 2011
Healthy user and related biases in observational studies of preventive interventions: a primer for physiciansWilliam H Shrank, Amanda R Patrick, M Alan Brookhart
BMC Health Services Research|March 28, 2003
Cost of managing complications resulting from type 2 diabetes mellitus in CanadaJudith A O'Brien, Amanda R Patrick, J Jaime Caro
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|January 21, 2014
The potential economic benefits of improved postfracture care: a cost-effectiveness analysis of a fracture liaison service in the US health-care systemDaniel H Solomon, Amanda R Patrick, John Schousboe, et al.
Pharmacoeconomics|October 27, 2007
Strategies for the management of suspected heparin-induced thrombocytopenia: a cost-effectiveness analysisAmanda R Patrick, Wolfgang C Winkelmayer, Jerry Avorn, et al.
Journal of Clinical Psychopharmacology|November 14, 2009
Health advisories and patterns of patient monitoring among new users of antidepressant medicationsJoshua J Gagne, Amanda R Patrick, Philip S Wang, et al.
Journal of the American College of Cardiology|February 12, 2011
The cost-effectiveness of C-reactive protein testing and rosuvastatin treatment for patients with normal cholesterol levelsNiteesh K Choudhry, Amanda R Patrick, Robert J Glynn, et al.
The Journal of Clinical Endocrinology and Metabolism|July 8, 2011
The economics of improving medication adherence in osteoporosis: validation and application of a simulation modelAmanda R Patrick, John T Schousboe, Elena Losina, et al.
BMC Health Services Research|September 4, 2003
Cost of managing an episode of relapse in multiple sclerosis in the United StatesJudith A O'Brien, Alexandra J Ward, Amanda R Patrick, et al.
Pageof 6